A Study to Investigate Safety, Tolerability, and Pharmacokinetics of AZD7503 in Participants With Suspected NASH.
Clinical trial NCT05864391 · TERMINATED
Trial details
- NCT number
- NCT05864391
- Sponsor
- AstraZeneca
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-31
- Primary completion
- 2024-03-20
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.